BACK to Live Meetings

Held: September 23-24, 2016
Mount Carmel Education Center
7333 Smith’s Mill Road
New Albany, Ohio 43054

View / Download Slides

Access Post Program Survey

Conference Overview:

Joint providers, University of Cincinnati and MedEd Consulting, Inc., in collaboration with the North American Neurotoxin Association (NANA) and the North Central Headache Society (NCHS) are organizing a 1.5-Day Conference.

The goal of the conference, Update on Craniofacial Pain and Dystonia, is to educate practitioners in the mechanism of action, therapeutic rationale, and clinical application of botulinum neurotoxin in the management of patients with head and neck dysfunction. The NANA/NCHS Tandem Conference is offering up to 9.5 AMA PRA Category 1 Credits ™.

The North American Neurotoxin Association (NANA) is a multidisciplinary organization created to educate physicians and other healthcare professionals concerned with the fundamental principles surrounding and appropriate usage of botulinum toxin injections. NANA provides several ACCME accredited educational events annually. The programs are fully interactive with case-based presentations and workshops that review the mechanism of action, therapeutic rationale, and clinical application of botulinum neurotoxin.

The North Central Headache Society (NCHS), previously known as the Ohio Headache Association, has conducted educational activities since its inception in the late 1990s. Founded by Drs. Robert Kunkel and Robert Smith, the society’s membership includes headache physicians from Ohio, Pennsylvania, Indiana, Kentucky and West Virginia. The society has also sponsored research projects that have investigated the relationship between migraines and comorbid medical conditions.

Target Audience:

This course is designed for physicians, including neurologists, pediatricians, internists, family medicine physicians, physiatrists, and pain specialists as well as nurse practitioners, physician assistants, registered nurses, physical therapists, residents, students, practitioners treating head, neck, and facial pain, and all other healthcare professionals with an interest in the clinical application of botulinum neurotoxin in the management of patients with head and neck dysfunction.

Learning Objectives:

At the conclusion of this activity, learners will be able to:

  • Discuss the mechanism of action and the conceptual basis for the use of therapeutic botulinum neurotoxin therapy in patients with oromandibular dystonia and bruxism / temporomandibular dysfunction, blepharospasm, cervical dystonia, migraine headache, cervicogenic headache, and neck pain
  • Summarize the scientific data on the analgesic properties of BoNT in treating patients with head and neck dysfunction
  • Explain the safety and efficacy of botulinum serotypes approved by the FDA for clinical use
  • Describe the diagnosis and treatments for facial pain and headache in pediatrics
  • Review the clinical criteria for the classification of migraine and inpatient refractory headaches
  • Discuss the association between headaches and sleep apnea, bruxism/temporomandibular dysfunction, allergies and sinus disorders
  • Identify techniques for the safe and effective injection of botulinum toxin/nerve blocks/sphenocath for headaches


North American Neurotoxin Association (David Riley, M.D. Chairman)

Friday September 23, 2016 – 6:15pm to 9:30pm

6:00pm – 6:15pm Registration
6:15pm – 6:30pm Welcome and Introductions  David Riley, MD
6:30pm – 7:15pm The Differential Diagnosis and Management of Oromandibular Dystonia  Jeff Okeson, DMD
7:15pm – 8:00pm Case Studies in Cervical Dystonia  Khashayar Dashtipour, MD, PhD
8:00pm – 8:15pm Break
8:15pm – 8:45pm Billing and Coding Update  Martin Taylor, DO, PhD
8:45pm – 9:30pm Case studies in Blepharospasm and Facial Spasms  David Riley, M.D
9:30pm Adjourn

North Central Headache Society (Martin Taylor, D.O., Ph.D. Chairman)

Saturday September 24, 2016 – 8:00am to 4:05pm

7:30am – 8:00am Breakfast and Industry Booths
8:00am – 8:20am Welcome and Introductions Martin Taylor, DO, PhD
8:20am – 9:00am Role of Bruxism / Temporomandibular Dysfunction in Headache Jeff Okeson, DMD
9:00am – 9:40am Sleep Disorders in Headache Rebecca L. Michael, MD
9:40am – 10:10am Botulinum Toxin Therapy for Cervicogenic Headache and Neck Pain Laxman Bahroo, DO
10:10am – 10:30am Break
10:30am – 11:10am Emerging Treatments for Migraine Stewart Tepper, MD
11:10am – 11:50am The Role of Allergies and Sinus Disorders in Headache and Facial Pain Vince Martin, MD
11:50am – 12:25pm Lunch Break
12:25pm – 1:10pm Inpatient Treatment of Refractory Headache MaryAnn Mays, MD
1:10pm – 1:50pm Neuropathic Facial Pain Kevin Weber, MD
1:50pm – 2:00pm Break
2:00pm – 3:00pm Pediatric and Adult Cases of Atypical Headache and Facial Pain Ann Pakalnis, MD
3:00pm – 4:00pm Injections for Headache Demonstration (Botulinum Toxin/Nerve Blocks/Sphenocath) Martin Taylor, DO, PhD
4:00pm – 4:05pm Program Post Assessment and Evaluation

Course Directors:

David E. Riley, MDDavid E. Riley, MD
Chair of Medical Education
Cleveland, OH

Martin Taylor, DO, PhDMartin Taylor, DO, PhD
Neurology / OrthoNeuro
Clinical Associate Professor, Neurology
Ohio University College of Osteopathic Medicine
Columbus, OH


Laxman Bahroo, DOLaxman Bahroo, DO
Director Botulinum Toxin Clinic
Director Neurology Residency Program
Associate Professor of Neurology
Georgetown University Hospital
Washington, DC

Khashayar Dashtipour, MD, PhDKhashayar Dashtipour, MD, PhD
Associate Professor Neurology & Basic Sciences
Director, Division of Movement Disorders
Department of Neurology/Movement Disorders
Loma Linda University School of Medicine
Loma Linda, CA

Vince Martin, MDVince Martin, MD
Professor of Medicine, University of Cincinnati School of Medicine
Director, UC Headache and Facial Pain Program
UC Health Physicians Office (Clifton)
Cincinnati, OH

MaryAnn Mays, MDMaryAnn Mays, MD
Staff Neurologist
Director, Neurology Residency Program
Headache Center
Center for Neurological Restoration, Neurological Institute
Cleveland Clinic
Cleveland, OH

Rebecca L. Michael, MDRebecca L. Michael, MD
Headache Fellow
Cleveland Clinic Center for Neurological Restoration
Cleveland, OH

Jeff Okeson, DMDJeff Okeson, DMD
Professor and Director Orofacial Pain Center
University of Kentucky
Lexington, Kentucky

Ann Pakalnis, MDAnn Pakalnis, MD
Professor of Clinical Pediatrics and Neurology
The Ohio State University College of Medicine
Director, Comprehensive Headache Clinic
Nationwide Children’s Hospital
Columbus, OH

David E. Riley, MDDavid E. Riley, MD
Chair of Medical Education
Cleveland, OH

Martin Taylor, DO, PhDMartin Taylor, DO, PhD
Neurology / OrthoNeuro
Clinical Associate Professor, Neurology
Ohio University College of Osteopathic Medicine
Columbus, OH

Stewart Tepper, MDStewart Tepper, MD
Professor of Neurology
Geisel School of Medicine at Dartmouth
Hanover, New Hampshire

Kevin Weber, MD, MHAKevin Weber, MD, MHA
Assistant Professor of Neurology
The Ohio State University Neurological Institute
Department of Neurology
Columbus, OH

Registration Fee:

There is a $50 registration fee for this educational activity. A full refund will be provided for cancellations up to 30 days prior to the event.

Faculty Disclosure Declaration:

According to the disclosure policy of the University of Cincinnati College of Medicine, all faculty, planning committee members, and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interest related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. Disclosure will be made at the time of activity.


This activity will be planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and MedEd Consulting, Inc. The University of Cincinnati is accredited by the ACCME to provide continuing education for physicians.

AMA Credit Designation Statement:

The University of Cincinnati designates this Live Activity for a maximum of 9.5 AMA PRA Category 1 Credits ™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of Cincinnati designates this activity for up to 9.5 hours of participation for continuing education for allied health professionals.

Jointly Provided by:




Instructions to Receive Credit:

In order to receive credit for this activity, the participant must complete the pre test, post test, evaluation, and claim for credit forms upon completion of the activity.

Hotel Accommodations:

The Courtyard Columbus New Albany is sold out.

If hotel accommodations are needed, the Hampton Inn and Suites New Albany Columbus Hotel is

is conveniently located half a mile from Mount Carmel at 5220 Forest Drive, New Albany, OH 43054.

To book a reservation, call 614-855-8335 or go online:

Thank you to the following supporters of the 2016 Update on Craniofacial Pain and Dystonia conference.

This conference is supported by educational grants provided by:
Allergan, Inc.
Ipsen Biopharmaceuticals, Inc.
Merz Pharmaceuticals, LLC
US WorldMeds, LLC

Thank you to the following sponsors of the conference:

Allergan, Inc. – Chronic Migraine
Allergan, Inc. – Neuro Rehab

Merz Pharmaceuticals, LLC

AbbVie, Inc.
Avanir Pharmaceuticals, Inc.
EA Medical, LLC
Endo Pharmaceuticals
Genzyme Corporation
Ipsen Biopharmaceuticals, Inc.
Promius Pharma, LLC
Teva Pharmaceuticals USA – Neuroscience
US WorldMeds, LLC